GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SeqLL Inc (OTCPK:SEQL) » Definitions » Price-to-Tangible-Book

SeqLL (SEQL) Price-to-Tangible-Book : 1.94 (As of May. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is SeqLL Price-to-Tangible-Book?

As of today (2024-05-15), SeqLL's share price is $3.10. SeqLL's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $1.60. Hence, SeqLL's Price to Tangible Book Ratio of today is 1.94.

The historical rank and industry rank for SeqLL's Price-to-Tangible-Book or its related term are showing as below:

SEQL' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.79   Med: 2.59   Max: 2.72
Current: 1.94

During the past 7 years, SeqLL's highest Price to Tangible Book Ratio was 2.72. The lowest was 0.79. And the median was 2.59.

SEQL's Price-to-Tangible-Book is ranked better than
61.08% of 167 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.55 vs SEQL: 1.94

A closely related ratio is called PB Ratio. As of today, SeqLL's share price is $3.10. SeqLL's Book Value per Sharefor the quarter that ended in Dec. 2023 was $1.60. Hence, SeqLL's P/B Ratio of today is 1.94.


SeqLL Price-to-Tangible-Book Historical Data

The historical data trend for SeqLL's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeqLL Price-to-Tangible-Book Chart

SeqLL Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial - - 2.72 0.79 2.59

SeqLL Quarterly Data
Dec18 Mar19 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 1.31 1.93 3.30 2.59

Competitive Comparison of SeqLL's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, SeqLL's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SeqLL's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SeqLL's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where SeqLL's Price-to-Tangible-Book falls into.



SeqLL Price-to-Tangible-Book Calculation

SeqLL's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=3.10/1.597
=1.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


SeqLL Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of SeqLL's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


SeqLL (SEQL) Business Description

Traded in Other Exchanges
N/A
Address
3 Federal Street, Billerica, MA, USA, 01821
SeqLL Inc is an early commercial-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple omics fields. The company leverages its expertise with True Single Molecule Sequencing (tSMS) technology enabling researchers and clinicians to contribute advancements to scientific research and development by accelerating one's understanding of the molecular mechanisms of disease and fundamental biological processes, It enables researchers to identify and synthesize DNA or RNA strands, irrespective of abundance, in a biological sample and is capable of analyzing billions of molecules in parallel.
Executives
Douglas Patrick Miscoll director 317 NEW BOSTON STREET, SUITE 2010, WOBURN MA 01801
Daniel Robert Jones officer: President, CEO 317 NEW BOSTON STREET, SUITE 210, WOBURN MA 01801
David Pfeffer director 464 IVY AVENUE, HAWORTH NJ 07644
Patrice M. Milos director 317 NEW BOSTON STREET, SUITE 2010, WOBURN MA 01801
Frances P Scally officer: CHIEF FINANCIAL OFFICER 66 MELANIE LANE, SYOSSET NY 11791
John Whitcomb Kennedy officer: CFO, Secretary 166 WINN STREET, WOBURN MA 01801